Ngā hua rapu - Claus Høgdall

Whakamahine hua
  1. 1
    Prognostic value of the 2018 FIGO staging system for cervical cancer

    Prognostic value of the 2018 FIGO staging system for cervical cancer mā Abdulaziz Mohamud, Claus Høgdall, Tine Henrichsen Schnack

    I whakaputaina 2022
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  2. 2
    Potential use of DNA methylation in cervical swabs for early ovarian cancer diagnosis

    Potential use of DNA methylation in cervical swabs for early ovarian cancer diagnosis mā Edyta Biskup, Joanna Lopacinska‐Jørgensen, Claus Høgdall, Estrid Høgdall

    I whakaputaina 2025
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  3. 3
    Soluble Urokinase Plasminogen Activator Receptor Measurements: Influence of Sample Handling

    Soluble Urokinase Plasminogen Activator Receptor Measurements: Influence of Sample Handling mā Rikke Riisbro, Ib Jarle Christensen, Claus Høgdall, Nils Brünner, Estrid Høgdall

    I whakaputaina 2001
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  4. 4
    Lymph-vascular space invasion (LVSI) as a strong and independent predictor for non-locoregional recurrences in endometrial cancer: a Danish Gynecological Cancer Group Study

    Lymph-vascular space invasion (LVSI) as a strong and independent predictor for non-locoregional recurrences in endometrial cancer: a Danish Gynecological Cancer Group Study mā Gitte Ørtoft, Lisa Lausten-Thomsen, Claus Høgdall, Estrid Stæhr Hansen, Margit Dueholm

    I whakaputaina 2019
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  5. 5
    Ovarian sex cord-stromal cell tumors and the risk of sex hormone-sensitive cancers

    Ovarian sex cord-stromal cell tumors and the risk of sex hormone-sensitive cancers mā Sven Karstensen, Kirsten Jochumsen, Claus Høgdall, Estrid Høgdall, Niels Marcussen, Finn Friis Lauszus

    I whakaputaina 2025
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  6. 6
    Different Risk Factor Profiles for Mucinous and Nonmucinous Ovarian Cancer: Results from the Danish MALOVA Study

    Different Risk Factor Profiles for Mucinous and Nonmucinous Ovarian Cancer: Results from the Danish MALOVA Study mā Marie Soegaard, Allan Jensen, Estrid Høgdall, Lise Christensen, Claus Høgdall, Jan Blaakær, Susanne K. Kjær

    I whakaputaina 2007
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  7. 7
    Oncomine™ Comprehensive Assay v3 vs. Oncomine™ Comprehensive Assay Plus

    Oncomine™ Comprehensive Assay v3 vs. Oncomine™ Comprehensive Assay Plus mā Lau K. Vestergaard, Douglas V.N.P. Oliveira, Tim Svenstrup Poulsen, Claus Høgdall, Estrid Høgdall

    I whakaputaina 2021
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  8. 8
    Identification and validation of potential prognostic and predictive miRNAs of epithelial ovarian cancer

    Identification and validation of potential prognostic and predictive miRNAs of epithelial ovarian cancer mā Kira Philipsen Prahm, Claus Høgdall, Mona Aarenstrup Karlsen, Ib Jarle Christensen, Guy Wayne Novotny, Estrid Høgdall

    I whakaputaina 2018
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  9. 9
    Danish Gynecological Cancer Database

    Danish Gynecological Cancer Database mā S. Soerensen, Signe Frahm Bjørn, Kirsten Jochumsen, Pernille Tine Jensen, Ingrid Thranov, Helle Hare‐Bruun, Lene Seibæk, Claus Høgdall

    I whakaputaina 2016
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  10. 10
    Risk of recurrence, prognosis, and follow‐up for Danish women with cervical cancer in 2005‐2013: A national cohort study

    Risk of recurrence, prognosis, and follow‐up for Danish women with cervical cancer in 2005‐2013: A national cohort study mā Gry Assam Taarnhøj, Ib Jarle Christensen, Henrik Lajer, Katrine Fuglsang, Mette Moustgaard Jeppesen, Henriette Strøm Kahr, Claus Høgdall

    I whakaputaina 2017
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  11. 11
    Distribution of HER‐2 overexpression in ovarian carcinoma tissue and its prognostic value in patients with ovarian carcinoma

    Distribution of HER‐2 overexpression in ovarian carcinoma tissue and its prognostic value in patients with ovarian carcinoma mā Estrid Høgdall, Lise Christensen, Susanne K. Kjær, Jan Blaakær, Johannes E. Bock, Eva Glud, Bent Nørgaard‐Pedersen, Claus Høgdall

    I whakaputaina 2003
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  12. 12
    Prognostic value of estrogen receptor and progesterone receptor tumor expression in Danish ovarian cancer patients: From the ‘MALOVA’ Ovarian Cancer Study

    Prognostic value of estrogen receptor and progesterone receptor tumor expression in Danish ovarian cancer patients: From the ‘MALOVA’ Ovarian Cancer Study mā Susanne K. Kjær, Ib Jarle Christensen, Ian Jacobs, Simon A. Gayther, Lise Christensen, Claus Høgdall, Jan Blaakær, Estrid Høgdall

    I whakaputaina 2007
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  13. 13
    Hormone Therapy and the Impact of Estrogen Intake on the Risk of Ovarian Cancer

    Hormone Therapy and the Impact of Estrogen Intake on the Risk of Ovarian Cancer mā Eva Glud, Susanne K. Kjær, Birthe Lykke Thomsen, Claus Høgdall, Lise Christensen, Estrid Høgdall, Johannes E. Bock, Jan Blaakær

    I whakaputaina 2004
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  14. 14
    Socioeconomic Position and Stage of Cervical Cancer in Danish Women Diagnosed 2005 to 2009

    Socioeconomic Position and Stage of Cervical Cancer in Danish Women Diagnosed 2005 to 2009 mā Else Helene Ibfelt, Susanne K. Kjær, Christoffer Johansen, Claus Høgdall, Marianne Steding‐Jessen, Kirsten Frederiksen, Birgitte Frederiksen, Merete Osler, Susanne Oksbjerg Dalton

    I whakaputaina 2012
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  15. 15
    Diagnostic plasma miRNA-profiles for ovarian cancer in patients with pelvic mass

    Diagnostic plasma miRNA-profiles for ovarian cancer in patients with pelvic mass mā Douglas V.N.P. Oliveira, Anting Liu Carlsen, Niels H. H. Heegaard, Kira Philipsen Prahm, Ib Jarle Christensen, Claus Høgdall, Estrid Høgdall

    I whakaputaina 2019
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  16. 16
    'Socioeconomic position and survival after cervical cancer: influence of cancer stage, comorbidity and smoking among Danish women diagnosed between 2005 and 2010

    'Socioeconomic position and survival after cervical cancer: influence of cancer stage, comorbidity and smoking among Danish women diagnosed between 2005 and 2010 mā Else Helene Ibfelt, Susanne K. Kjær, Claus Høgdall, Marianne Steding‐Jessen, Trille Kristina Kjær, Merete Osler, Christoffer Johansen, Kirsten Frederiksen, Susanne Oksbjerg Dalton

    I whakaputaina 2013
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  17. 17
    YKL-40 tissue expression and plasma levels in patients with ovarian cancer

    YKL-40 tissue expression and plasma levels in patients with ovarian cancer mā Estrid Høgdall, Merete Ringsholt, Claus Høgdall, Ib Jarle Christensen, Julia S. Johansen, Susanne K. Kjær, Jan Blaakær, Lene Ostenfeld-Møller, Paul A. Price, Lise Christensen

    I whakaputaina 2009
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  18. 18
    <i>BRCA1</i> and <i>BRCA2</i> Mutation Prevalence and Clinical Characteristics of a Population-Based Series of Ovarian Cancer Cases from Denmark

    <i>BRCA1</i> and <i>BRCA2</i> Mutation Prevalence and Clinical Characteristics of a Population-Based Series of Ovarian Cancer Cases from Denmark mā Marie Soegaard, Susanne K. Kjær, Mark J. Cox, Eva Wozniak, Estrid Høgdall, Claus Høgdall, Jan Blaakær, Ian Jacobs, Simon A. Gayther, Susan J. Ramus

    I whakaputaina 2008
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  19. 19
    <scp>HE</scp>4 and <scp>CA</scp>125 levels in the preoperative assessment of endometrial cancer patients: a prospective multicenter study (<scp>ENDOMET</scp>)

    <scp>HE</scp>4 and <scp>CA</scp>125 levels in the preoperative assessment of endometrial cancer patients: a prospective multicenter study (<scp>ENDOMET</scp>) mā Sofie Leisby Antonsen, Estrid Høgdall, Ib Jarle Christensen, Magnus Christian Lydolph, Ann Tabor, Annika Loft Jakobsen, Carsten Lindberg Fagö-Olsen, E. Andersen, Kirsten Jochumsen, Claus Høgdall

    I whakaputaina 2013
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  20. 20
    Prognostic relevance of the molecular classification in high-grade endometrial cancer for patients staged by lymphadenectomy and without adjuvant treatment

    Prognostic relevance of the molecular classification in high-grade endometrial cancer for patients staged by lymphadenectomy and without adjuvant treatment mā Alicia León‐Castillo, Nanda Horeweg, Elke E.M. Peters, Tessa Rutten, Natalja T. ter Haar, Vincent T.H.B.M. Smit, Cor D. de Kroon, Marie Boennelycke, Estrid Høgdall, Claus Høgdall, Remi R.A. Nout, Carien L. Creutzberg, Gitte Ørtoft, Tjalling Bosse

    I whakaputaina 2022
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:

Ngā utauta rapu: